Wealth Management Associates, Inc. Dexcom Inc Transaction History

Wealth Management Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 May 28, 2025	SELL	$64.0 - $116.06 $139,072 - $252,198	-2,173 Closed	0 $0
Q1 2024 May 28, 2025	BUY	$114.22 - $140.1 $7,310 - $8,966	64 Added 3.03%	2,173 $246 Million
Q4 2023 May 28, 2025	BUY	$75.49 - $124.16 $159,208 - $261,853	2,109 New	2,109 $262 Million

1,083

362M

5.4M

4.3M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Wealth Management Associates, Inc. with notifications on news.